Suven Life Gets Patent For Neuro-Degenerative Drug

New Delhi: Drug firm Suven Life Sciences has been granted a patent each by Eurasia and Norway for a drug used in the treatment of neuro-degenerative diseases.  In a BSE filing today, Suven Life said it has been granted "one product patent from Eurasia and one product patent from Norway corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases".  The patents are valid...